Amarin Reports Third Quarter 2024 Financial Results and Provides Business Update
Amarin Announces Two Upcoming Investor Events
Prilenia Appoints Rob Lauzen as Chief Financial Officer and Jason Marks as Chief Legal Officer
Affinia Therapeutics Announces the Appointment of Rami Daoud as Chief Business and Financial Officer
Research Highlighting the Clinical Impact of VASCEPA®/VAZKEPA (icosapent ethyl) in Patients with Diabetes and High Cardiovascular Risk and the Anti-Lp(a) Oxidation Mechanistic Effect of Eicosapentaenoic Acid (EPA) to be Presented at the 60th Annual Europe